Dr Andrew Thompson
Senior Consultant
I am a Senior Consultant in LCP’s Health Analytics team. Since completing my PhD in 2013, I have worked in clinical and genetic epidemiology at UCL and the University of Liverpool and have published >35 peer-reviewed journal articles.
I have extensive experience of handling large datasets to answer questions relevant to disease susceptibility, drug utilisation and long-term health outcomes.
In addition, I have worked with colleagues in the NHS to implement and evaluate new tools/services with the aim of improving patient care and outcomes.
I am an active member of several international consortia that range in scope from genetic susceptibility of disease onset to guidelines for pharmacotherapy utilisation.
Working with LCP feels like being part of a bigger team. The collaborative approach is a breath of fresh air compared with previous advisors.
Our latest thinking
How I have helped our clients
Related publications
Our health analytics approach leverages the increasing availability of data and our cutting-edge modelling approaches to put timely actionable data in the hands of key stakeholders.
We integrate a wealth of health and health-related datasets and develop bespoke interactive visualisations to make it accessible and rapid for clients to glean insights across a range of areas.
Multimorbidity, living with two or more conditions is one of the biggest challenges facing patients and health systems today. We leverage real world datasets and innovative approaches to generate evidence that identifies patient groups with the greatest unmet needs in a more holistic manner that reflects the drivers of ill health.
Supporting our clients to achieve equitable health outcomes is a golden thread throughout our work. We combine our expertise to translate evidence into change and apply population health analytics to help reduce inequalities in health and health outcomes.
We apply scientific rigour to evaluate the economic and clinical value of healthcare interventions using both traditional and innovative perspectives and methods.
